Evidence map›Paper›PMID 41618151›Full record

ArticleBMC cardiovascular disorders2026

Assessment of the prevalence and associated risk factors of QT prolongation, with a focus on medication use, among patients with cardiovascular disease referred to Shahid Chamran Heart Hospital.

Mehrnoush Dianatkhah, Mahnaz Momenzadeh, Alireza Almasi, Saeide Bahrani, Ehsan Shirvani, Zahra Teimouri-Jervekani

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mehrnoush DianatkhahDepartment of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahnaz MomenzadehDepartment of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran. Mahnaz.Momenzadeh@pharm.mui.ac.ir.
Alireza AlmasiDepartment of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran.
Saeide BahraniHypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Ehsan ShirvaniInterventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra Teimouri-JervekaniDepartment of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven the importance of LQTS and its association with potentially fatal ventricular arrhythmias, assessing its prevalence across diverse populations is crucial. This study aims to determine the prevalence of LQTS and its associated risk factors among patients with cardiovascular disease admitted to a heart hospital in Iran, particularly focusing on medication use.

methodUpon arrival at the emergency department, all patients were evaluated, and relevant data, including medication use, past medical history, and laboratory test results, were extracted from their medical records. Additionally, a 12-lead ECG was obtained from each patient at admission. In this study, the QT interval was reported using the Hodges formulas. QTc thresholds were defined according to both the 2009 AHA/ACCF/HRS guideline and the 99th percentile reference values.

resultA total of 371 individuals presenting to the emergency department of Shahid Chamran Heart Hospital were included in this study. According to the 2009 guideline, 64 (17.25%) patients were diagnosed with LQTS, and, using the Hodges formula and considering the 99th percentile cutoff, 31 (8.35%) had QT intervals above the 99th percentile. Out of 64 patients diagnosed with LQTS, 27 (42.18%) were using QT-prolonging medications. Furthermore, a significant correlation was observed between medication use and the incidence of LQTS.

conclusionThe prevalence of LQTS observed in the present study was slightly higher than in other studies, which may be attributed to the selection of a cardiac patient population. A significant correlation was observed between medication use and the incidence of LQTS.

Indexed as

Cardiovascular AgentsCardiovascular DiseasesHeart Conduction SystemHeart RateLong QT SyndromeAction PotentialsAdultAgedElectrocardiographyEmergency Room VisitsEmergency Service, HospitalFemaleHumansIranMaleMiddle AgedCardiovascular AgentsCardiovascular diseaseLong QT syndromePrevalenceVentricular arrhythmias

Identifiers

PMID41618151
PMCPMC12930686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.